MedPath

FLAVIO CADEGIANI ENDOCRINOLOGIA E SERVICOS MEDICOS LTDA

🇧🇷Brazil
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

2 Phases

Phase 2:2
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (66.7%)
Phase 3
1 (33.3%)

The South Proxa-Rescue AndroCoV Trial Against COVID-19

Phase 3
Completed
Conditions
COVID-19
Interventions
Drug: Placebo
First Posted Date
2021-11-19
Last Posted Date
2021-11-19
Lead Sponsor
Corpometria Institute
Target Recruit Count
133
Registration Number
NCT05126628
Locations
🇧🇷

Corpometria Institute, Brasília, DF, Brazil

EAT-DUTA AndroCoV Trial

Phase 2
Completed
Conditions
Covid19
Interventions
First Posted Date
2021-01-28
Last Posted Date
2021-01-28
Lead Sponsor
Corpometria Institute
Target Recruit Count
138
Registration Number
NCT04729491
Locations
🇧🇷

Corpometria Institute, Brasília, DF, Brazil

The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial)

First Posted Date
2021-01-15
Last Posted Date
2021-01-15
Lead Sponsor
Corpometria Institute
Target Recruit Count
294
Registration Number
NCT04712279

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.